0001209191-18-063956.txt : 20181221 0001209191-18-063956.hdr.sgml : 20181221 20181221171113 ACCESSION NUMBER: 0001209191-18-063956 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181219 FILED AS OF DATE: 20181221 DATE AS OF CHANGE: 20181221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ZACCARDELLI DAVID CENTRAL INDEX KEY: 0001627642 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38135 FILM NUMBER: 181250441 MAIL ADDRESS: STREET 1: 300 TRI STATE INTERNATIONAL STREET 2: SUITE 272 CITY: LINCOLNSHIRE STATE: IL ZIP: 60069 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dova Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001685071 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813858961 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 240 LEIGH FARM ROAD CITY: DURHAM STATE: NC ZIP: 27707 BUSINESS PHONE: 919-806-4487 MAIL ADDRESS: STREET 1: 240 LEIGH FARM ROAD CITY: DURHAM STATE: NC ZIP: 27707 FORMER COMPANY: FORMER CONFORMED NAME: Dova Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20160919 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-12-19 0 0001685071 Dova Pharmaceuticals Inc. DOVA 0001627642 ZACCARDELLI DAVID C/O DOVA PHARMACEUTICALS, INC. 240 LEIGH FARM ROAD, SUITE 245 DURHAM NC 27707 0 1 0 0 President & CEO Common Stock 2018-12-19 4 A 0 82372 A 82372 D Common Stock 2018-12-20 4 P 0 10000 6.07 A 92372 D Employee Stock Option (right to buy) 6.07 2018-12-19 4 A 0 1000000 0.00 A 2028-12-18 Common Stock 1000000 1000000 D Represents a restricted stock unit ("RSU") award that vests 50% on June 28, 2019 and 25% on each of September 30, 2019 and December 31, 2019. Each RSU represents a contingent right to receive one share of Issuer common stock. 25% of the total shares subject to the option shall vest on December 17, 2019, and 1/48th of total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service with the Issuer as of each such date. /s/ Mark Ballantyne, Attorney-in-Fact 2018-12-21